Condition: Colorectal Cancer · Sponsor: Tempus AI
The study is an observational multicenter evaluation of participants with colorectal cancer (CRC) who will receive longitudinal plasma ctDNA biomarker profiling in addition to their standard-of-care therapy and disease surveillance.
This description comes directly from the study's public registry record.
CRC Surveillance Study · (833) 514-4187 · gemini-crc@tempus.com
Always discuss trial participation with your own doctor first.
| Mercy Clinic Oncology - Fort Smith | Fort Smith, Arkansas, United States | Recruiting |
| MemorialCare | Fountain Valley, California, United States | Recruiting |
| The Center for Cancer and Blood Disorders | Bethesda, Maryland, United States | Recruiting |
| Mercy Clinic Oncology and Hematology - Joplin | Joplin, Missouri, United States | Recruiting |
| Mercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center | Springfield, Missouri, United States | Recruiting |
| Washington University School of Medicine | St Louis, Missouri, United States | Recruiting |
| Mercy Clinic Oncology and Hematology - Sindelar Cancer Center | St Louis, Missouri, United States | Recruiting |
| Mercy Clinic Oncology and Hematology - David C. Pratt Cancer Center | St Louis, Missouri, United States | Recruiting |
| Nebraska Cancer Specialists | Omaha, Nebraska, United States | Recruiting |
| Southeastern Medical Oncology Center | Goldsboro, North Carolina, United States | Recruiting |
| Aultman Hospital | Canton, Ohio, United States | Recruiting |
| TriHealth Cancer Institute | Cincinnati, Ohio, United States | Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05234177